Showing 20 of 59 recruiting trials for “chromophobe-renal-cell-carcinoma”
Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells
Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma
RecruitingNCT06720532 ↗
Kidney Function and Risk Factors in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Undergoing 177Lutetium-PSMA Radioligand Therapy: a Prospective Observational Study - KiRi-Trial
68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma
CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer
RecruitingNCT06548867 ↗
Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
👨⚕️ Ramaprasad Srinivasan, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Apr 2024View details ↗
A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors
"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"
Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)
👨⚕️ Tian Zhang, MD, University of Texas Southwestern Medical Center📍 1 site📅 Started Dec 2023View details ↗
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
👨⚕️ Fei Li, M.D, The First Affiliated Hospital of Nanchang University📍 1 site📅 Started Nov 2023View details ↗
A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)
RecruitingNCT06391879 ↗
Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
RecruitingNCT06076538 ↗
PET/MR for Characterization of Renal Masses (RMs)
👨⚕️ Ivan Pedrosa, MD, PhD, University of Texas Southwestern Medical Center📍 1 site📅 Started Aug 2023View details ↗
Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors
Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma
👨⚕️ Fangjian Zhou, Professor, Director of Dept. of Urology, Sun Yat-sen University Cancer Center📍 8 sites📅 Started Apr 2023View details ↗
RecruitingNCT05184790 ↗
LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →